Free Trial

Transcat FY2025 EPS Estimate Decreased by Northland Capmk

Transcat logo with Computer and Technology background

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Northland Capmk decreased their FY2025 earnings estimates for shares of Transcat in a research report issued to clients and investors on Wednesday, October 30th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $1.88 per share for the year, down from their prior forecast of $2.00. The consensus estimate for Transcat's current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat's FY2027 earnings at $2.69 EPS and FY2028 earnings at $2.99 EPS.

Several other equities research analysts have also issued reports on the company. StockNews.com lowered Transcat from a "hold" rating to a "sell" rating in a research report on Tuesday. Oppenheimer restated an "outperform" rating and issued a $130.00 price target (down from $155.00) on shares of Transcat in a research report on Wednesday. Northland Securities lowered their price objective on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research report on Wednesday. HC Wainwright reissued a "buy" rating and issued a $156.00 target price on shares of Transcat in a report on Tuesday. Finally, Craig Hallum lowered their target price on Transcat from $138.00 to $113.00 and set a "buy" rating for the company in a report on Wednesday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $127.25.

Read Our Latest Stock Analysis on Transcat

Transcat Stock Down 0.2 %

NASDAQ:TRNS traded down $0.16 during trading hours on Friday, reaching $95.41. 120,824 shares of the stock were exchanged, compared to its average volume of 53,096. The stock has a market capitalization of $873.00 million, a P/E ratio of 48.19 and a beta of 0.67. The firm has a 50 day simple moving average of $121.71 and a 200-day simple moving average of $121.89. Transcat has a 52 week low of $84.45 and a 52 week high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 7.62% and a net margin of 6.63%. The business's revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.41 EPS.

Institutional Investors Weigh In On Transcat

A number of hedge funds have recently made changes to their positions in the business. Quadrature Capital Ltd acquired a new stake in Transcat in the first quarter worth about $619,000. Calamos Advisors LLC boosted its holdings in shares of Transcat by 76.0% in the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company's stock valued at $1,848,000 after acquiring an additional 6,667 shares in the last quarter. First Horizon Advisors Inc. increased its stake in shares of Transcat by 26.4% during the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company's stock valued at $72,000 after acquiring an additional 125 shares during the period. Quest Partners LLC bought a new stake in Transcat during the second quarter worth approximately $109,000. Finally, Annex Advisory Services LLC lifted its position in Transcat by 61.4% in the third quarter. Annex Advisory Services LLC now owns 16,568 shares of the scientific and technical instruments company's stock worth $2,001,000 after purchasing an additional 6,304 shares during the period. Institutional investors own 98.34% of the company's stock.

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Should you invest $1,000 in Transcat right now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines